- Company Overview for NUCLEOME THERAPEUTICS LIMITED (12109297)
- Filing history for NUCLEOME THERAPEUTICS LIMITED (12109297)
- People for NUCLEOME THERAPEUTICS LIMITED (12109297)
- More for NUCLEOME THERAPEUTICS LIMITED (12109297)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
16 May 2024 | AP01 | Appointment of John Davis as a director on 15 February 2024 | |
16 May 2024 | TM01 | Termination of appointment of Danuta Mariola Jeziorska as a director on 19 April 2024 | |
20 Feb 2024 | PSC05 | Change of details for Oxford Science Enterprises Plc as a person with significant control on 26 August 2023 | |
15 Feb 2024 | SH01 |
Statement of capital following an allotment of shares on 14 February 2024
|
|
04 Jan 2024 | AA | Accounts for a small company made up to 31 July 2023 | |
13 Dec 2023 | SH01 |
Statement of capital following an allotment of shares on 13 December 2023
|
|
08 Nov 2023 | SH01 |
Statement of capital following an allotment of shares on 8 September 2023
|
|
08 Nov 2023 | SH01 |
Statement of capital following an allotment of shares on 26 August 2023
|
|
07 Sep 2023 | AP01 | Appointment of Dr Russell George Greig as a director on 6 September 2023 | |
07 Aug 2023 | CS01 | Confirmation statement made on 7 August 2023 with updates | |
02 Mar 2023 | AP01 | Appointment of Miss Emma Johnson as a director on 2 March 2023 | |
14 Dec 2022 | AA | Accounts for a small company made up to 31 July 2022 | |
14 Dec 2022 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 10 November 2022
|
|
25 Nov 2022 | RP04PSC05 | Second filing to change the details of Oxford Science Enterprises Plc as a person with significant control | |
25 Nov 2022 | RP04AP03 | Second filing for the appointment of Phil Boyd as a secretary | |
14 Nov 2022 | SH02 | Sub-division of shares on 21 October 2022 | |
14 Nov 2022 | SH08 | Change of share class name or designation | |
14 Nov 2022 | SH10 | Particulars of variation of rights attached to shares | |
04 Nov 2022 | SH01 |
Statement of capital following an allotment of shares on 21 October 2022
|
|
01 Nov 2022 | RP04AP01 | Second filing for the appointment of Rana Al-Hallaq as a director | |
01 Nov 2022 | RP04AP01 | Second filing for the appointment of Dr Fiona Caroline Maclaughlin as a director | |
01 Nov 2022 | RP04AP01 | Second filing for the appointment of Bauke Anninga as a director | |
26 Oct 2022 | AP01 |
Appointment of Rana Al-Hallaq as a director on 11 October 2022
|
|
26 Oct 2022 | RESOLUTIONS |
Resolutions
|
|
26 Oct 2022 | MA | Memorandum and Articles of Association |